So They Say

People on the Private Side I set up the [National Cancer Institute’s biological response modification program beginning in 1980, and I left in February of 1984, and during that time I actually was trying to get more private involvement, to get a closer interface with the biotechnology industry, to get rotating scientists in from outside to try to open up and liberalize some of the viewpoints within the N.C.I. system.... They almost totally rejected it. It was a real closed shop in ter


Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

People on the Private Side

I set up the [National Cancer Institute’s biological response modification program beginning in 1980, and I left in February of 1984, and during that time I actually was trying to get more private involvement, to get a closer interface with the biotechnology industry, to get rotating scientists in from outside to try to open up and liberalize some of the viewpoints within the N.C.I. system....

They almost totally rejected it. It was a real closed shop in terms of thought processes. Many of the people have been there all their lives. They’ve spent very little time at the university and virtually none in the private sector. So they’re very focused on what they do at the N.I.H. or N.C.I., and I think they have a little trouble seeing the forest for the trees. They’re very suspicious that things done outside have somehow got a prurient ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours